The first electronic pill controlled by mobile phone has been created

For the first time researchers in the US have created the world’s first electronic capsule, which is swallowed and then controlled by smartphone wirelessly via Bluetooth.

The electronic pill can either diagnose a problem in the body and then transmit the relevant information wirelessly, or carry medication inside the body, or both, depending on the instructions given by the operator (the doctor or the same patient) via the smartphone.

The capsule, produced from a three-dimensional printer and remains in the stomach for at least one month (before being split into smaller pieces and expelled via the digestive tract), can be used for the p************l treatment of various diseases, especially those requiring long-term drug administration. It is also possible to diagnose infections, allergies and other disorders and then release some medication (antibiotic, antihistamine, etc.).

Researchers, led by Robert Langer of MIT University, who published in Advanced Materials Technologies, reported that the capsule can communicate wirelessly with other medical devices that the patient either bears or implanted .

The technology of electronic sensors and pills swallowed is an ever-growing field internationally. The new capsule contains portions of soft and hard polymeric materials in which it is possible to store medications that are gradually released over time after the commands given via the Bluetooth connection.

It also contains sensors that constantly monitor the gastric environment, temperature and other elements, which instantly send wirelessly to the cell phone, says the RES-ICU.

Limited bandwidth (rather than Wi-Fi) connection has been deliberately made to increase cyber-security of the device in the user’s area and to prevent signal interception from medical information for the patient.

The device is ontrolled by a small battery, but alternative energy sources such as a tiny external antenna or even stomach acid are already being explored. Currently, the capsule has been tested in pigs and in about two years is expected to begin testing in humans. Already researchers have created a company to develop new medical technology in patients.